When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Emergency Use CHOP Research Institute Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy The Peptide Craze Ground Truths